BTIG Maintains Buy on Alto Neuroscience, Raises Price Target to $28

Alto Neuroscience, Inc. -3.56%

Alto Neuroscience, Inc.

ANRO

22.23

-3.56%

BTIG analyst Thomas Shrader maintains Alto Neuroscience (NYSE: ANRO) with a Buy and raises the price target from $27 to $28.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via